{"id":40570,"date":"2025-06-16T12:28:02","date_gmt":"2025-06-16T10:28:02","guid":{"rendered":"https:\/\/www.idisantiago.es\/?post_type=project&#038;p=40570"},"modified":"2026-08-18T14:07:41","modified_gmt":"2026-08-18T12:07:41","slug":"lugo-1","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/gl\/grupo-de-investigacion\/lugo-1\/","title":{"rendered":"CardioHULA"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||0px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.idisantiago.es\/gl\/grupos-de-investigacion\/\"><strong>GRUPOS DE INVESTIGACI\u00d3N<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<h1>Grupo CardioHULA<\/h1>\n<p>&nbsp;<\/p>\n<p>CATEGOR\u00cdA: <span style=\"color: #003366;\">GRUPOS COLABORADORES<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image title_text=&#8221;Logo-CardioHULA&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Objetivos<\/h3>\n<p>Desde el grupo de investigaci\u00f3n CardioHULA nos hemos centrado en diferentes \u00e1reas de estudio o l\u00edneas de investigaci\u00f3n cl\u00ednicas como son la inflamaci\u00f3n en la enfermedad cardiovascular, la endocarditis infecciosa o la enfermedad coronaria. En los \u00faltimos a\u00f1os, nuestros esfuerzos se han orientado hacia una investigaci\u00f3n traslacional b\u00e1sico-cl\u00ednica orientada al estudio de nuevas dianas terap\u00e9uticas y pron\u00f3sticas.<\/p>\n<h3>L\u00edneas de investigaci\u00f3n<\/h3>\n<p>Investigaci\u00f3n cl\u00ednica:<\/p>\n<ul>\n<li>Enfermedad coronaria. Dra. Rosa Alba Abell\u00e1s<\/li>\n<li>S\u00edndrome coronario agudo. Dr. Jerem\u00edas Bay\u00f3n &amp; Dra. Mar\u00eda Abell\u00e1s Sequeiros<\/li>\n<li>Stents bioabsorbible. Dra. Rosa Alba Abell\u00e1s<\/li>\n<li>Cardiotoxicidad. \/ Sdre. CardioRenal. Dr. Jos\u00e9 Mar\u00eda Vi\u00e9itez Florez<\/li>\n<li>Insuficiencia card\u00edaca. Dra. Andrea L\u00f3pez L\u00f3pez<\/li>\n<li>Rehabilitaci\u00f3n Card\u00edaca. Dra. Eva Mar\u00eda Pereira L\u00f3pez<\/li>\n<li>Electrofisiolog\u00eda y arritmias. Dra. Juliana Elices Teja<\/li>\n<li>Inflamaci\u00f3n y enfermedad cardiovascular. B\u00fasqueda de nuevas dianas terape\u00faticas y marcadores de inflamaci\u00f3n. Dr. Carlos Gonz\u00e1lez Juanatey.<\/li>\n<li>Riesgo Cardiovascular. Dr. Carlos Gonz\u00e1lez Juanatey.<\/li>\n<li>Endocarditis infecciosa y Valvulopat\u00edas. Dra. Ana Testa Fern\u00e1ndez.<\/li>\n<li>Cardiopat\u00edas familiares. Dra. Charigan Abou Jokh Casas.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Investigaci\u00f3n traslacional:<\/p>\n<ul>\n<li>Biomarcadores, nuevas dianas. Dr. Carlos Gonz\u00e1lez Juanatey<\/li>\n<li>Inflamaci\u00f3n y enfermedad cardiovascular. Dr. Carlos Gonz\u00e1lez Juanatey<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Equipo investigador&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\"><strong>L\u00edder<\/strong><br \/>Gonz\u00e1lez Juanatey, Carlos<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Miembros<\/strong><br \/>Abell\u00e1s, Sequeiros, Mar\u00eda<br \/>Elices Teja, Juliana<br \/>Gonz\u00e1lez Melchor, Laila<br \/>Gonz\u00e1lez Mor\u00e1n, Mar\u00eda<br \/>Jokh Casas, Charigan Abou<br \/>L\u00f3pez L\u00f3pez, Andrea<br \/>Mori Junco, Ricardo Antonio<br \/>Pereira L\u00f3pez, Eva Mar\u00eda<br \/>Platero V\u00e1zquez, Victoria<br \/>Puebla Rojo, V\u00edctor Manuel<br \/>Regueiro Abel, Margarita<br \/>Ricaud R\u00edos, Alejandra Guadalupe<br \/>R\u00edos V\u00e1zquez, Ram\u00f3n<br \/>Rivas V\u00e1zquez, Estefan\u00eda<br \/>Seoane Garc\u00eda, Tania<br \/>Testa Fern\u00e1ndez, Ana<br \/>V\u00e1zquez Ara\u00fajo, Ant\u00eda<\/p>\n<\/td>\n<td style=\"width: 50%;\">\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Proyectos&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&#8211; PI16\/ 01816. Papel de las ciclofilinas y su receptor EMPRIM (CD147) en las enfermedades ateroscler\u00f3ticas y su modulaci\u00f3n con compuestos de origen marino. Proyecto nacional en la convocatoria AES 2016 financiado por el ISCIII. Proyecto coordinado con la USC. IP Dr. Carlos Gonz\u00e1lez Juanatey.<\/p>\n<p>&#8211; PI19\/00879. Niveles de ciclofilinas como biomarcadores de enfermedad coronaria (CAD). Evaluaci\u00f3n de inhibidores espec\u00edficos de ciclofilinas como protectores cardiovasculares. Proyecto nacional en la convocatoria AES 2019 financiado por el ISCIII. Proyecto coordinado con la USC. IP Dr. Carlos Gonz\u00e1lez Juanatey.<\/p>\n<p>&#8211; IN607B 2022\/05. En el a\u00f1o 2022 le ha sido concedida al servicio, por parte de la Axencia Galega de Innovaci\u00f3n de la Xunta de Galicia, una serie de ayudas del Programa de Consolidaci\u00f3n y Estructuraci\u00f3n de Unidades de Investigaci\u00f3n Competitivas, dentro de la modalidad de Grupos con Potencial de Crecimiento.<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publicaciones&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&#8211; Alfonso A, Bay\u00f3n J, Gegunde S, Alonso E, Alvari\u00f1o R, Sant\u00e1s-\u00c1lvarez M, Testa-Fern\u00e1ndez A, Rios-V\u00e1zquez R, Gonz\u00e1lez-Juanatey C, Botana LM. High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease. Sci Rep. 2019 Jul 22;9(1):10576. doi: 10.1038\/s41598-019-46988-x. PMID: 31332225; PMCID: PMC6646393.<\/p>\n<p>&#8211; Bay\u00f3n J, Sant\u00e1s-\u00c1lvarez M, Ocaranza-S\u00e1nchez R, Gonz\u00e1lez-Juanatey C. Bioresorbable magnesium scaffold in complex PCI in a nickel allergy patient: one-year follow-up &#8211; no disease, no scaffolds. EuroIntervention. 2019 Sep 20;15(7):640-641. doi: 10.4244\/EIJ-D-18-00400. PMID: 30418158.<\/p>\n<p>&#8211; Bayon J, Alfonso A, Gegunde S, Alonso E, Alvarino R, Santas-Alvarez M, Testa-Fernandez A, Rios-Vazquez R, Botana L, Gonzalez-Juanatey C. Cyclophilins in Ischemic Heart Disease: Differences Between Acute and Chronic Coronary Artery Disease Patients. Cardiol Res. 2020 Oct;11(5):319-327. doi: 10.14740\/cr1120. Epub 2020 Aug 1. PMID: 32849967; PMCID: PMC7430890.<\/p>\n<p>&#8211; Abellas-Sequeiros RA, Ocaranza-Sanchez R, Bayon-Lorenzo J, Santas-Alvarez M, Gonzalez-Juanatey C. 12-month clinical outcomes after Magmaris percutaneous coronary intervention in a real-world cohort of patients: Results from the CardioHULA registry. Rev Port Cardiol (Engl Ed). 2020 Aug;39(8):421-425. English, Portuguese. doi: 10.1016\/j.repc.2019.09.018. Epub 2020 Aug 3. PMID: 32763098.<\/p>\n<p>&#8211; Bay\u00f3n J, Alfonso A, Sant\u00e1s-\u00c1lvarez M, Alonso E, Testa-Fern\u00e1ndez A, R\u00edos-V\u00e1zquez R, Ocaranza-S\u00e1nchez R, Abell\u00e1s-Sequeiros RA, Elices-Teja J, Botana L, Gonz\u00e1lez-Juanatey C. Aumento de niveles s\u00e9ricos de Ciclofilina C en el seguimiento de la enfermedad arterial coronaria: un biomarcador y posible predictor cl\u00ednico [Increase of serum cyclophilin C levels in the follow-up of coronary artery disease: A biomarker and possible clinical predictor]. Arch Cardiol Mex. 2022 Apr 4;92(2):189-195. doi: 10.24875\/ACM.20000498. PMID: 34594052; PMCID: PMC9005183.<\/p>\n<p>&#8211; Gonz\u00e1lez-Juanatey C, Anguita-S\u00e1nchez M, Barrios V, N\u00fa\u00f1ez-Gil I, G\u00f3mez-Doblas JJ, Garc\u00eda-Moll X, Lafuente-Gormaz C, Roll\u00e1n-G\u00f3mez MJ, Peral-Disdier V, Mart\u00ednez-Dolz L, Rodr\u00edguez-Santamarta M, Vi\u00f1olas-Prat X, Soriano-Colom\u00e9 T, Mu\u00f1oz-Aguilera R, Plaza I, Curcio-Ruig\u00f3mez A, Orts-Soler E, Segovia J, Fanjul V, Cequier \u00c1, Savana Research Group. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. J Clin Med. 2022 Oct 11;11(20):6004. doi: 10.3390\/jcm11206004. PMID: 36294325; PMCID: PMC9605132.<\/p>\n<p>&#8211; Lopez-L\u00f3pez A, Franco-Guti\u00e9rrez R, P\u00e9rez-P\u00e9rez AJ, Regueiro-Abel M, Elices-Teja J, Abou-Jokh-Casas C, Gonz\u00e1lez-Juanatey C. Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study. J Clin Med. 2023 May 22;12(10):3595. doi: 10.3390\/jcm12103595. PMID: 37240702; PMCID: PMC10219257.<\/p>\n<p>&#8211; Cabanas-Grand\u00edo P, Gonz\u00e1lez-Melchor L, Caama\u00f1o MV, Windcheid EF, Babarro EG, Bob\u00edn OD, Portela MP, Delgado OP, Teja JE, Feijoo MG, Freire E, Castro OD, Garc\u00eda JM, Garc\u00eda-Seara J, Gonz\u00e1lez-Juanatey C. Health-Related Quality of Life and Satisfaction in Atrial Fibrillation Patients on Anticoagulant Therapy: Differences between Vitamin K Antagonists and Direct Oral Anticoagulants; Results from the Multicentre REGUEIFA Registry. J Clin Med. 2024 Sep 6;13(17):5283. doi: 10.3390\/jcm13175283. PMID: 39274496; PMCID: PMC11395996.<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Web del grupo&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>https:\/\/<\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Investigadora l\u00edder<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-40148\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"40609\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar \"  href=https:\/\/www.idisantiago.es\/gl\/team\/carlos-gonzalez-juanatey\/ target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"40609\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2025\/06\/Dr-Juanatey-320x320.png\" src=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2025\/06\/Dr-Juanatey-320x320.png\" alt=\"Carlos Gonz\u00e1lez Juanatey\" width=\"320\" height=\"320\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tCarlos Gonz\u00e1lez Juanatey\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-profession\">\n\t\t\t<h4>Investigador l\u00edder del grupo CardioHULA<\/h4>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>carlos.gonzalez.juanatey@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; GRUPOS DE INVESTIGACI\u00d3N &nbsp; Grupo CardioHULA &nbsp; CATEGOR\u00cdA: GRUPOS COLABORADORESObjetivos Desde el grupo de investigaci\u00f3n CardioHULA nos hemos centrado en diferentes \u00e1reas de estudio o l\u00edneas de investigaci\u00f3n cl\u00ednicas [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":40590,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[891],"project_tag":[],"class_list":["post-40570","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-grupos-colaboradores-gl"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/40570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/comments?post=40570"}],"version-history":[{"count":4,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/40570\/revisions"}],"predecessor-version":[{"id":49334,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/40570\/revisions\/49334"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media\/40590"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media?parent=40570"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_category?post=40570"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_tag?post=40570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}